The ROE as of December 2025 (TTM) for Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) is 13.81%

According to Eyebright Medical Technology (Beijing) Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 13.81%. This represents a change of 300.70% compared to the average of 3.45% of the last 4 quarters.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) Historical ROE (quarterly & annually)

How has 688050.SS ROE performed in the past?

The mean historical ROE of Eyebright Medical Technology (Beijing) Co., Ltd. over the last ten years is 7.91%. The current 13.81% ROE has changed 74.61% with respect to the historical average. Over the past ten years (40 quarters), 688050.SS's ROE was at its highest in in the June 2020 quarter at 5.21%. The ROE was at its lowest in in the March 2020 quarter at 0.55%.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Eyebright Medical Technology (Beijing) Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) Average ROE

How has 688050.SS ROE performed in the past?

The current ROE of Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) ROE vs. Peers

How is 688050.SS’s ROE compared to its peers?

Eyebright Medical Technology (Beijing) Co., Ltd.’s ROE is less than Sansure Biotech Inc. (3.75%), less than Autek China Inc. (10.22%), less than Shanghai MicroPort Endovascular MedTech Co., Ltd. (9.67%), less than LBX Pharmacy Chain Joint Stock Company (6.20%), less than Tofflon Science and Technology Group Co., Ltd. (2.21%), less than Mayinglong Pharmaceutical Group Co., Ltd. (13.63%), less than Xiamen Kingdomway Group Company (11.00%), less than Guobang Pharma Ltd. (10.70%), less than China National Accord Medicines Corporation Ltd. (2.96%), less than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (17.27%),

Build a custom stock screener for Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eyebright Medical Technology (Beijing) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eyebright Medical Technology (Beijing) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.